Highlights and Quick Summary
- Annual Accounts Receivable Turnover for 2021 was 8.26 (a 613.92% increase from previous year)
- Annual Accounts Receivable Turnover for 2020 was 1.16 (a -68.68% decrease from previous year)
- Annual Accounts Receivable Turnover for 2019 was 3.69 (a -6.9% decrease from previous year)
- Twelve month Accounts Receivable Turnover ending September 30, 2022 was 6.93 (a 17.6% increase compared to previous quarter)
- Twelve month trailing Accounts Receivable Turnover decreased by -16.1% year-over-year
Trailing Accounts Receivable Turnover for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| 6.93 | 5.89 | 6.86 | 8.26 |
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Accounts Receivable Turnover of BioCryst Pharmaceuticals, Inc.
Most recent Accounts Receivable Turnoverof BCRX including historical data for past 10 years.Interactive Chart of Accounts Receivable Turnover of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. Accounts Receivable Turnover for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | 8.26 |
| 2020 | – | – | – | – | 1.16 |
| 2019 | – | – | – | – | 3.69 |
| 2018 | – | – | – | – | 3.97 |
| 2017 | – | – | – | – | 3.38 |
| 2016 | – | – | – | – | 3.51 |
| 2015 | – | – | – | – | 6.13 |
| 2014 | – | – | – | – | 2.35 |
| 2013 | – | – | – | – | 5.19 |
| 2012 | – | – | – | – | 5.06 |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology